U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07875959) titled '18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors' on Aug. 09.
Brief Summary: Renal cell carcinoma and renal pelvic urothelial carcinoma are common malignant tumors of the urinary system. Accurate preoperative differentiation between these tumor types is important for treatment planning, while conventional imaging methods may have limitations in characterizing tumor biology.
Nectin-4 is a tumor-associated molecular target that is highly expressed in several epithelial malignancies, particularly urothelial carcinoma. 18F-N230A is a novel PET imaging probe targeting Nectin-4. This study aims to evaluate the safety, biod...